人类血小板溶解酸:对脑内出血的潜在治疗方法
Dachang Qiu1, Lin Wang1, Lanlan Wang2
1Wuxi School of Medicine, Jiangnan University, Wuxi, China.
Frontiers in neuroscience
|January 30, 2025
概括
人类血小板溶解物 (HPL) 通过减少炎症和促进大脑修复,显示出治疗脑内出血 (ICH) 的前景. 需要进一步的研究,以优化HPL治疗ICH患者.
科学领域:
- 神经科学是一个神经科学.
- 再生医学是一种再生医学.
- 生物医学工程 生物医学工程
背景情况:
- 脑内出血 (ICH) 是一个严重的全球健康负担,死亡率和残疾率很高.
- 目前ICH的治疗方法有限,特别是在二次损伤阶段,因为对分子机制的理解不足.
- 人类血小板溶解物 (HPL) 拥有众多生物活性因子,在神经疾病中具有证明的治疗潜力.
研究的目的:
- 审查人类血小板溶解体 (HPL) 作为脑内出血 (ICH) 的治疗策略的潜力.
- 探索在ICH中实施HPL处理的理由,机制和必要考虑因素.
- 综合当前关于HPL在ICH病理生理学和临床前研究中的作用的知识.
主要方法:
- 对临床前研究和关于HPL和ICH的现有研究的文献综述.
- 对HPL成分,制备方法和生物活性分子的分析.
- 阐明HPL的治疗机制,包括抗神经炎症和神经原体效应.
主要成果:
- HPL表现出与ICH相关的抗神经炎症,抗氧化,血脑屏障保护和神经发生促进的特性.
- 血小板在ICH病理生理学中发挥着至关重要的作用,HPL利用它们的再生潜力.
- 临床前研究表明,HPL在神经系统疾病 (包括ICH) 中具有有前途的应用.
结论:
- HPL代表了一种有前途的治疗途径,用于管理脑内出血.
- 了解HPL的生物活性分子和机制是其在ICH有效应用的关键.
- 需要进一步的研究和开发来应对挑战,并优化基于HPL的ICH治疗方法.
相关概念视频
Formation of the Platelet Plug
4.0K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.0K
Introduction to Hemostasis
5.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.2K
Structure and Function of Platelets
966
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
966
Clot Retraction and Fibrinolysis
3.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
602
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
602
Extrinsic and Intrinsic Pathways of Hemostasis
5.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.0K


